BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 18387499)

  • 1. Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients.
    Ohki T; Tateishi R; Sato T; Masuzaki R; Imamura J; Goto T; Yamashiki N; Yoshida H; Kanai F; Kato N; Shiina S; Yoshida H; Kawabe T; Omata M
    Clin Gastroenterol Hepatol; 2008 Apr; 6(4):459-64. PubMed ID: 18387499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
    N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis.
    Aizawa Y; Shibamoto Y; Takagi I; Zeniya M; Toda G
    Cancer; 2000 Jul; 89(1):53-9. PubMed ID: 10897000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon.
    Ikeda M; Fujiyama S; Tanaka M; Sata M; Ide T; Yatsuhashi H; Watanabe H
    J Gastroenterol; 2005 Feb; 40(2):148-56. PubMed ID: 15770398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
    Nair S; Mason A; Eason J; Loss G; Perrillo RP
    Hepatology; 2002 Jul; 36(1):150-5. PubMed ID: 12085359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
    Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
    Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M
    Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Ohata K; Hamasaki K; Toriyama K; Matsumoto K; Saeki A; Yanagi K; Abiru S; Nakagawa Y; Shigeno M; Miyazoe S; Ichikawa T; Ishikawa H; Nakao K; Eguchi K
    Cancer; 2003 Jun; 97(12):3036-43. PubMed ID: 12784339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan.
    Inoue M; Yoshimi I; Sobue T; Tsugane S;
    J Natl Cancer Inst; 2005 Feb; 97(4):293-300. PubMed ID: 15713964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C.
    Hamada H; Yatsuhashi H; Yano K; Daikoku M; Arisawa K; Inoue O; Koga M; Nakata K; Eguchi K; Yano M
    Cancer; 2002 Jul; 95(2):331-9. PubMed ID: 12124834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.
    Lai MS; Hsieh MS; Chiu YH; Chen TH
    Hepatology; 2006 Jun; 43(6):1295-302. PubMed ID: 16729295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Ohata K; Hamasaki K; Toriyama K; Ishikawa H; Nakao K; Eguchi K
    J Gastroenterol Hepatol; 2004 Jun; 19(6):670-5. PubMed ID: 15151623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatocellular carcinoma: rising incidence of hepatitis C virus-associated cases at a university clinic in Germany].
    Erhardt A; Theobald I; Petry W; Röhrborn A; Heintges T; Wettstein M; Häussinger D
    Dtsch Med Wochenschr; 2002 Dec; 127(50):2665-8. PubMed ID: 12481236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma.
    Marrero JA; Fontana RJ; Fu S; Conjeevaram HS; Su GL; Lok AS
    J Hepatol; 2005 Feb; 42(2):218-24. PubMed ID: 15664247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses.
    Wang CS; Yao WJ; Chang TT; Wang ST; Chou P
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2054-60. PubMed ID: 19549812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The obesity paradox: body mass index and outcomes in patients with heart failure.
    Curtis JP; Selter JG; Wang Y; Rathore SS; Jovin IS; Jadbabaie F; Kosiborod M; Portnay EL; Sokol SI; Bader F; Krumholz HM
    Arch Intern Med; 2005 Jan; 165(1):55-61. PubMed ID: 15642875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of anti-HBc seropositivity on the risk of hepatocellular carcinoma in HCV-infected patients after adjusting for confounding factors.
    Ohki T; Tateishi R; Goto E; Sato T; Masuzaki R; Imamura J; Goto T; Kanai F; Kato N; Shiina S; Yoshida H; Kawabe T; Omata M
    J Viral Hepat; 2010 Feb; 17(2):91-7. PubMed ID: 19566786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.